Results 111 to 120 of about 2,408 (179)
Lipoprotein A and the Association With Peripheral Arterial Disease: A Review of the Risk in Peripheral Arterial Disease. [PDF]
Rev Cardiovasc MedKar S.
europepmc +1 more source
From Risk to Resilience: Transforming Perinatal Management for Women with FH. [PDF]
J Atheroscler ThrombOgura M.
europepmc +1 more source
Cholesterol Levels Are Not Associated with Peripheral Blood Stem Cell Mobilization in Healthy Donors. [PDF]
J Clin MedSeçilmiş S +9 more
europepmc +1 more source
Liver transplantation for homozygous familial hypercholesterolaemia. [PDF]
Curr Opin LipidolThompson GR, Walji S, Cegla J.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Hypercholesterolemia and LDL Apheresis
The International Journal of Artificial Organs, 2005Several trials have assessed the link between low-density lipoprotein cholesterol (LDL) and the development of coronary heart disease (CHD). LDL apheresis provides an effective role in treating patients with familial hypercholesterolemia (FH) and in preventing the progression of coronary artery disease (CAD).
F. Morelli +6 more
openaire +2 more sources
Immunosorbents for LDL-Apheresis
Biomaterials, Artificial Cells and Artificial Organs, 1990Low density lipoprotein (LDL) (1,03-1,05 g/ml) was utilized as antigen to obtain polyclonal (PcAb) and monoclonal (McAb) antibodies. Immunosorbents capable of selective removing LDL from human plasma were developed on the basis of the antibodies preparation.
S N, Pokrovsky +2 more
openaire +2 more sources
Transfusion and Apheresis Science, 2017
LDL apheresis has been developed as the treatment for refractory familial hypercholesterolemia (FH). Currently, plasma exchange, double membrane filtration, and selective LDL adsorption are available in Japan, and selective LDL adsorption is most common method. LDL apheresis can prevent atherosclerosis progression even in homozygous (HoFH). However, in
Hisashi, Makino +2 more
openaire +2 more sources
LDL apheresis has been developed as the treatment for refractory familial hypercholesterolemia (FH). Currently, plasma exchange, double membrane filtration, and selective LDL adsorption are available in Japan, and selective LDL adsorption is most common method. LDL apheresis can prevent atherosclerosis progression even in homozygous (HoFH). However, in
Hisashi, Makino +2 more
openaire +2 more sources
Atherosclerosis, 2003
Low density lipoprotein (LDL) apheresis provides a safe and effective means of treating patients with homozygous familial hypercholesterolaemia (FH). It also has a role in preventing the progression of coronary artery disease in heterozygotes and others with severe dyslipidaemia who are refractory to or intolerant of high doses of lipid-lowering drugs.
openaire +2 more sources
Low density lipoprotein (LDL) apheresis provides a safe and effective means of treating patients with homozygous familial hypercholesterolaemia (FH). It also has a role in preventing the progression of coronary artery disease in heterozygotes and others with severe dyslipidaemia who are refractory to or intolerant of high doses of lipid-lowering drugs.
openaire +2 more sources